MedTrace Logo

A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers

NCT06408948 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-07-22

No results posted yet for this study

Summary

Evaluate the Mass Balance of \[14C\]SHR7280 in Healthy Adult Volunteers.

Conditions

  • Assisted Reproduction

Interventions

DRUG

[14C]SHR7280

Patients will receive single dose of orally \[14C\]SHR7280 on Day 1.

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-07
Primary Completion
2024-07-06
Completion
2024-07-06

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06408948 on ClinicalTrials.gov